In this task, you are given a text of many news articles seperated by special token "|||||". Your task is to summarize them.
Q: (CNN) An antibiotic-resistant superbug launched on a SpaceX Falcon 9 rocket Sunday from the same Kennedy Space Center launch complex where the first manned mission to the moon lifted off and the bug will be studied by astronauts on the International Space Station. 
  
 Before you start to worry, this isn't a sign of an impending apocalypse. Working in conjunction with NASA, lead researcher Dr. Anita Goel hopes that by sending MRSA bacteria to a zero-gravity environment, we can better understand how superbugs mutate to become resistant to available antibiotics. 
  
 Methicillin-resistant Staphylococcus aureus or MRSA , sometimes called a staph, is resistant to the antibiotic methicillin and many others. It can cause a variety of health problems including sepsis, pneumonia and skin and bloodstream infections. 
  
 Goel is a medical doctor and a physicist. She's also chairwoman and CEO of her lab and company, Nanobiosym which seeks out breakthroughs and technologies that span and combine physics, biomedicine and nanotechnology. 
  
 "We are excited to put MRSA on the International Space Station and investigate the effects of microgravity on the growth and mutation patterns of these bugs," Goel said at a NASA news conference last week. "I have this hypothesis that microgravity will accelerate the mutation patterns. If we can use microgravity as an accelerator to fast-forward and get a sneak preview of what these mutations will look like, then we can essentially build smarter drugs on Earth." 
  
 Goel is also interested to see the changes in the gene expression patterns of this bacteria. 
  
 The space station is essentially an orbiting lab where hundreds of experiments are carried out every day. The zero-gravity, or microgravity, environment has already been host to research on bacteria. The ISS itself has a "microbiome" of bacteria based on the comings and goings of astronauts. In 2016, DNA was sequenced for the first time aboard the station. 
  
 This all connects back to Goel's initial interest in the effect of an environment on DNA and what can be retrieved from it. 
  
 "The DNA is like a piano. The info in the DNA sequence is only part of what makes the music of an organism," she said. "The info embedded in the environment interplays with what is embedded in the DNA sequence, and together, they determine the music that the organism plays." 
  
 Research has shown that the "stressful conditions" of the space station's zero gravity cause fungi to grow faster . Goel hopes that the ISS will work in a similar way for the bacteria to give us a predictive edge on superbugs. 
  
 "If indeed we can use the ISS as an accelerator, an incubator, to know what future mutations of superbugs like MRSA will be, we use that info to develop better algorithms on Earth to inform drug discovery and faster ways to get to smarter drugs that are more personalized and more precisely targeted to a bug or strain at hand. We can have those drugs ready before the mutations even show up on Earth." 
  
 For anyone concerned about delivering a superbug to astronauts within the cramped quarters of the space station, Goel offered reassurance that they will never come directly into contact with the bacteria. This isn't NASA's first rodeo with bacteria or superbugs on the station, she said. 
  
 Join the conversation See the latest news and share your comments with CNN Health on Facebook and Twitter. 
  
 The bacteria will be sealed with three levels of containment and tightly packaged, including a portable habitat that is protected from rapid depressurization and even the rigors of traveling on a rocket to the station. 
  
 Goel is curious to see the effects of not only microgravity on the bacteria but electromagnetic radiation and other unanticipated elements. Studying anything in space is going to afford new understanding across multiple fields, she said. 
  
 "I think the space station and microgravity is an excuse for us to relook at our accepted paradigms and ways of thinking from a fresh perspective, and once we do that, we learn new things and discover new ways of looking at old things and looking at old data in new ways." ||||| Image: SpaceX/Flickr 
  
 On Saturday, February 18th, a SpaceX Dragon capsule will shuttle a superbug into space that kills more Americans each year than emphysema, HIV/AIDS, Parkinson’s Disease, and homicide combined: Methicillin-resistant Staphylococcus aureus, more commonly known as MRSA. It’s on behalf of a study conducted by NASA and biomedicine company Nanobiosym, but I can’t help but feel like this was Elon Musk’s idea for a science fiction spec he’s working on. 
  
  
  
 To be fair, there’s a valid reason to send this particular strain of bacteria into space. On Earth, MRSA—which physically manifests like a bad staph infection on a person’s skin—is resistant to many penicillin-related drugs, including methicillin. The idea is that by sending MRSA into microgravity, where there’s reason to believe it may mutate faster, we can improve our understanding of how the deadly bug develops resistance in the first place. 
  
 Advertisement 
  
 “Microgravity may accelerate the rate of bacterial mutations,” Dr. Anita Goel of Nanobiosym, who’s leading the study, told Space.com. “If we can predict future mutations before they happen, we can build better drugs.” 
  
 This is far from the first time bacteria have been sent into space for the purpose of developing better treatments. Such experiments trace back to 1960, when a Russian satellite ferried disease-causing E. coli, Aerobacter aerogenes, and Staphylococcus into space, only to find that these bacteria could in fact survive in microgravity, according to the Washington Post. Since then, several strains of bacteria have been sent off Earth for observation, in some cases increasing their resistance to antibiotics, or altering their growth patterns. 
  
 In 2006, microbiologist Cheryl Nickerson sent salmonella aboard the Atlantis Space Shuttle to see how it would react in microgravity. After the salmonella was returned to Earth for further examination, Nickerson found it was killing mice at an abnormally fast rate. So yeah, not great. 
  
 Advertisement 
  
 Hopefully, this experiment will bring us closer to a cure for MRSA. As for the safety of the astronauts aboard the ISS right now, NASA assures us the bug will be kept at a high level of containment. 
  
 And maybe if we’re lucky, Elon Musk’s shitty sci-fi movie will never get made. |||||
A: 
NASA and a biomedicine company are sending a drug-resistant superbug into outer space, where it will be researched aboard the International Space Station. And while Gizmodo notes the plan sounds like "Elon Musk's idea for a science fiction spec he's working on," it will—hopefully—have actual scientific benefits. Dr. Anita Goel tells CNN she believes MRSA—aka staph—will mutate more quickly in zero gravity. This could allow researchers to see future forms of MRSA and develop antibiotics to fight them before they happen. And that would be great news, as MRSA currently kills more people in the US every year than HIV/AIDS, Parkinson's, emphysema, and homicide combined. The well-contained MRSA sample will be hitching a ride on a SpaceX Falcon 9 rocket launching Saturday in Florida.